Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population

NCT: NCT05902871 · ACTIVE_NOT_RECRUITING

NCT IDNCT05902871
StatusACTIVE_NOT_RECRUITING
Start Date2024-03-11
Completion2027-01

Brief Summary

The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OHT), or Normal Tension Glaucoma (NTG).

Frequently Asked Questions

What is Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population?

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population is a clinical trial registered under NCT05902871. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05902871?

The current status of NCT05902871 (Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population) is: ACTIVE_NOT_RECRUITING.

When did Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population start?

Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population started on 2024-03-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑